Reviv3 Expands Distribution of AXIL Hearing Protection and Performance Hearing Products through Agreement with Leading UK Distributor
LOS ANGELES, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Reviv3 Procare Company (“Reviv3” or the “Company”) (OTCQB: RVIV), an emerging global e-commerce consumer products company, entered into an agreement with GMK Ltd., (“GMK”), a leading shooting sports and tactical products distributor, to distribute AXIL hearing protection and performance hearing products in the UK.
This agreement will expand Reviv3’s distribution footprint in the UK and further enhance its presence across Europe. GMK, located in East Sussex, is a distributor of firearms and related accessories to shooting sports retailers, UK Police, Emergency Services and MoD.
Reviv3's AXIL hearing protection product line includes advance hearing protection earbuds, ear plugs and related accessories. These products use technological advances to actively and passively protect hearing while providing superior sound quality. The agreement with GMK includes the distribution of AXIL and Sig Sauer branded products.
Established in 1971, GMK is the leading UK importer and distributor of shotguns, rifles, ammunition and accessories for sports shooting, as well as supplying firearms, ammunition and accessories to UK law enforcement and the Ministry of Defense. GMK is part of the specialised Beretta Defence Technologies (BDT) Division whose core value is to be seen as a one-stop solution provider. GMK's objective is to offer the leading range of quality products for the country sports market as well as other markets where there is a demand for these products.
About Reviv3 Procare Company
Reviv3 Procare Company (OTCQB: RVIV) is an emerging global e-commerce consumer products company. The Company is a direct-to-consumer marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand and premium hair and skincare products under its in-house Reviv3 Procare brand - selling products in the United States, Canada, the European Union and throughout Asia. To learn more, please visit the Company's website at www.reviv3.com and, for the AXIL brand, visit www.goaxil.com.
This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as "anticipates," "expects," "intends," "plans," “will,” “may,” “should,” “could,” “would,” “guidance,” “outlook,” "confident that" and "believes," among others, generally identify forward-looking statements.
These forward-looking statements are based on currently available information, and management's beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management’s control and may cause Reviv3’s results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3's ability to grow net sales as anticipated and perform in accordance with guidance; (ii) our ability to generate sufficient revenue to support Reviv3’s operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives, including integrating the AXIL brand; (iv) Reviv3's ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of Reviv3's customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3's product costs and other costs of doing business, and reduce Reviv3's earnings; and (vi) the impact of unstable market and general economic conditions on Reviv3’s business, financial condition and stock price, including inflationary cost pressures, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict and ongoing impact of COVID-19, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.